nach oben

Erschienen in:

01.01.2015 | 2014 SSAT Plenary Presentation

The Value of Drains as a Fistula Mitigation Strategy for Pancreatoduodenectomy: Something for Everyone? Results of a Randomized Prospective Multi-institutional Study

verfasst von: Matthew T. McMillan, William E. Fisher, George Van Buren II, Amy McElhany, Mark Bloomston, Steven J. Hughes, Jordan Winter, Stephen W. Behrman, Nicholas J. Zyromski, Vic Velanovich, Kimberly Brown, Katherine A. Morgan, Charles Vollmer

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

A recent randomized, controlled trial investigating intraperitoneal drain use during pancreatoduodenectomy (PD) had a primary goal of assessing overall morbidity. It was terminated early with findings that routine elimination of drains in PD increases mortality and the severity and frequency of overall complications. Here, we provide a follow-up analysis of drain value in reference to clinically relevant postoperative pancreatic fistula (CR-POPF).

Methods

Nine institutions performed 137 PDs, with patients randomized to intraperitoneal drainage (N = 68) or no drainage (N = 69). The Fistula Risk Score (FRS), a 10-point scale derived from four validated risk factors for CR-POPF, facilitated risk adjustment between treatment groups.

Results

There was no difference in fistula risk between the two cohorts. Overall, CR-POPF rates were higher in the no drain group compared to the drain group (20.3 vs. 13.2 %; p = 0.269). Patients with negligible/low FRS risk had higher rates of CR-POPF when drains were used (14.8 vs. 4.0 %; p = 0.352). Conversely, there were significantly fewer CR-POPFs (12.2 vs. 29.5 %; p = 0.050) when drains were used with moderate/high risk patients. Lastly, moderate/high risk patients who suffered a CR-POPF had reduced 90-day mortality (22.2 vs. 42.9 %) when a drain was used.

Conclusion

The results of this analysis suggest that drains diminish the rate and severity of CR-POPF in patients with moderate/high risk, but they could possibly be avoided in the roughly one third of patients with negligible/low risk.

Pratt, W.B., et al., Clinical and economic validation of the International Study Group of Pancreatic Fistula (ISGPF) classification scheme. Ann Surg, 2007. 245(3): p. 443–51.PubMedCentralPubMedCrossRef

van Berge Henegouwen, M.I., et al., Incidence, risk factors, and treatment of pancreatic leakage after pancreaticoduodenectomy: drainage versus resection of the pancreatic remnant. J Am Coll Surg, 1997. 185(1): p. 18–24.PubMedCrossRef

Gouma, D.J., et al., Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg, 2000. 232(6): p. 786–95.PubMedCentralPubMedCrossRef

Callery, M.P., W.B. Pratt, and C.M. Vollmer, Jr., Prevention and management of pancreatic fistula. J Gastrointest Surg, 2009. 13(1): p. 163–73.PubMedCrossRef

Pratt, W., et al., Postoperative pancreatic fistulas are not equivalent after proximal, distal, and central pancreatectomy. J Gastrointest Surg, 2006. 10(9): p. 1264–78; discussion 1278–9.PubMedCrossRef

Vollmer, C.M., Jr., et al., A root-cause analysis of mortality following major pancreatectomy. J Gastrointest Surg, 2012. 16(1): p. 89–102; discussion 102–3.PubMedCrossRef

Sachs, T.E., et al., The pancreaticojejunal anastomotic stent: friend or foe? Surgery, 2013. 153(5): p. 651–62.PubMedCrossRef

Biehl, T. and L.W. Traverso, Is stenting necessary for a successful pancreatic anastomosis? Am J Surg, 1992. 163(5): p. 530–2.PubMedCrossRef

Poon, R.T., et al., External drainage of pancreatic duct with a stent to reduce leakage rate of pancreaticojejunostomy after pancreaticoduodenectomy: a prospective randomized trial. Ann Surg, 2007. 246(3): p. 425–33; discussion 433–5.PubMedCentralPubMedCrossRef

10.

Pessaux, P., et al., External pancreatic duct stent decreases pancreatic fistula rate after pancreaticoduodenectomy: prospective multicenter randomized trial. Ann Surg, 2011. 253(5): p. 879–85.PubMedCrossRef

11.

Winter, J.M., et al., Does pancreatic duct stenting decrease the rate of pancreatic fistula following pancreaticoduodenectomy? Results of a prospective randomized trial. J Gastrointest Surg, 2006. 10(9): p. 1280–90; discussion 1290.PubMedCrossRef

12.

Vanounou, T., et al., Selective administration of prophylactic octreotide during pancreaticoduodenectomy: a clinical and cost-benefit analysis in low- and high-risk glands. J Am Coll Surg, 2007. 205(4): p. 546–57.PubMedCrossRef

13.

Buchler, M., et al., Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg, 1992. 163(1): p. 125–30; discussion 130–1.PubMedCrossRef

14.

Pederzoli, P., et al., Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Italian Study Group. Br J Surg, 1994. 81(2): p. 265–9.PubMedCrossRef

15.

Rosenberg, L., P. MacNeil, and L. Turcotte, Economic evaluation of the use of octreotide for prevention of complications following pancreatic resection. J Gastrointest Surg, 1999. 3(3): p. 225–32.PubMedCrossRef

16.

Lowy, A.M., et al., Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann Surg, 1997. 226(5): p. 632–41.PubMedCentralPubMedCrossRef

17.

Sarr, M.G. and G. Pancreatic Surgery, The potent somatostatin analogue vapreotide does not decrease pancreas-specific complications after elective pancreatectomy: a prospective, multicenter, double-blinded, randomized, placebo-controlled trial. J Am Coll Surg, 2003. 196(4): p. 556–64; discussion 564–5; author reply 565.

18.

Ochiai, T., et al., Application of polyethylene glycolic acid felt with fibrin sealant to prevent postoperative pancreatic fistula in pancreatic surgery. J Gastrointest Surg, 2010. 14(5): p. 884–90.PubMedCrossRef

19.

Lillemoe, K.D., et al., Does fibrin glue sealant decrease the rate of pancreatic fistula after pancreaticoduodenectomy? Results of a prospective randomized trial. J Gastrointest Surg, 2004. 8(7): p. 766–72; discussion 772–4.PubMedCrossRef

20.

Suc, B., et al., Temporary fibrin glue occlusion of the main pancreatic duct in the prevention of intra-abdominal complications after pancreatic resection: prospective randomized trial. Ann Surg, 2003. 237(1): p. 57–65.PubMedCentralPubMedCrossRef

21.

Simo, K.A., et al., Hemostatic Agents in Hepatobiliary and Pancreas Surgery: A Review of the Literature and Critical Evaluation of a Novel Carrier-Bound Fibrin Sealant (TachoSil). ISRN Surg, 2012. 2012: p. 729086.PubMedCentralPubMedCrossRef

22.

Iannitti, D.A., et al., Use of the round ligament of the liver to decrease pancreatic fistulas: a novel technique. J Am Coll Surg, 2006. 203(6): p. 857–64.PubMedCrossRef

23.

Hassenpflug, M., et al., Decrease in clinically relevant pancreatic fistula by coverage of the pancreatic remnant after distal pancreatectomy. Surgery, 2012. 152(3 Suppl 1): p. S164-71.PubMedCrossRef

24.

Levy, M., Intraperitoneal drainage. Am J Surg, 1984. 147(3): p. 309–14.PubMedCrossRef

25.

Van Buren, G., 2nd, et al., A randomized prospective multicenter trial of pancreaticoduodenectomy with and without routine intraperitoneal drainage. Ann Surg, 2014. 259(4): p. 605–12.PubMedCrossRef

26.

Jeekel, J., No abdominal drainage after Whipple's procedure. Br J Surg, 1992. 79(2): p. 182.PubMedCrossRef

27.

Heslin, M.J., et al., Is intra-abdominal drainage necessary after pancreaticoduodenectomy? J Gastrointest Surg, 1998. 2(4): p. 373–8.PubMedCrossRef

28.

Conlon, K.C., et al., Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resection. Ann Surg, 2001. 234(4): p. 487–93; discussion 493–4.PubMedCentralPubMedCrossRef

29.

Fisher, W.E., et al., Pancreatic resection without routine intraperitoneal drainage. HPB (Oxford), 2011. 13(7): p. 503–10.CrossRef

30.

van der Wilt, A.A., et al., To drain or not to drain: a cumulative meta-analysis of the use of routine abdominal drains after pancreatic resection. HPB (Oxford), 2013. 15(5): p. 337–44.CrossRef

31.

Mehta, V.V., et al., Is it time to abandon routine operative drain use? A single institution assessment of 709 consecutive pancreaticoduodenectomies. J Am Coll Surg, 2013. 216(4): p. 635–42; discussion 642–4.PubMedCrossRef

32.

Correa-Gallego, C., et al., Operative drainage following pancreatic resection: analysis of 1122 patients resected over 5 years at a single institution. Ann Surg, 2013. 258(6): p. 1051–8.PubMedCrossRef

33.

Veillette, G., et al., Implications and management of pancreatic fistulas following pancreaticoduodenectomy: the Massachusetts General Hospital experience. Arch Surg, 2008. 143(5): p. 476–81.PubMedCentralPubMedCrossRef

34.

Molinari, E., et al., Amylase value in drains after pancreatic resection as predictive factor of postoperative pancreatic fistula: results of a prospective study in 137 patients. Ann Surg, 2007. 246(2): p. 281–7.PubMedCentralPubMedCrossRef

35.

Bassi, C., et al., Pancreatic fistula rate after pancreatic resection. The importance of definitions. Dig Surg, 2004. 21(1): p. 54–9.PubMedCrossRef

36.

Bassi, C., et al., Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery, 2005. 138(1): p. 8–13.PubMedCrossRef

37.

Pratt, W.B., M.P. Callery, and C.M. Vollmer, Jr., Risk prediction for development of pancreatic fistula using the ISGPF classification scheme. World J Surg, 2008. 32(3): p. 419–28.PubMedCrossRef

38.

Callery, M.P., et al., A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. J Am Coll Surg, 2013. 216(1): p. 1–14.

39.

Miller, B.C., et al., A multi-institutional external validation of the fistula risk score for pancreatoduodenectomy. J Gastrointest Surg, 2014. 18(1): p. 172–79; discussion 179–80.PubMedCrossRef

40.

Gurusamy, K.S., et al., Routine abdominal drainage for uncomplicated laparoscopic cholecystectomy. Cochrane Database Syst Rev, 2007(4): p. CD006004.PubMed

41.

Karliczek, A., et al., Drainage or nondrainage in elective colorectal anastomosis: a systematic review and meta-analysis. Colorectal Dis, 2006. 8(4): p. 259–65.PubMedCrossRef

42.

de Rougemont, O., et al., Abdominal drains in liver transplantation: useful tool or useless dogma? A matched case–control study. Liver Transpl, 2009. 15(1): p. 96–101.PubMedCrossRef

43.

Aldameh, A., J.L. McCall, and J.B. Koea, Is routine placement of surgical drains necessary after elective hepatectomy? Results from a single institution. J Gastrointest Surg, 2005. 9(5): p. 667–71.PubMedCrossRef

44.

Bassi, C., et al., Early versus late drain removal after standard pancreatic resections: results of a prospective randomized trial. Ann Surg, 2010. 252(2): p. 207–14.PubMedCrossRef

45.

Nagakawa, Y., et al., Bacterial contamination in ascitic fluid is associated with the development of clinically relevant pancreatic fistula after pancreatoduodenectomy. Pancreas, 2013. 42(4): p. 701–6.PubMedCrossRef

46.

Strobel, O. and M.W. Buchler, Drainage after pancreaticoduodenectomy: controversy revitalized. Ann Surg, 2014. 259(4): p. 613–5.PubMedCrossRef

Titel: The Value of Drains as a Fistula Mitigation Strategy for Pancreatoduodenectomy: Something for Everyone? Results of a Randomized Prospective Multi-institutional Study
verfasst von: Matthew T. McMillan
William E. Fisher
George Van Buren II
Amy McElhany
Mark Bloomston
Steven J. Hughes
Jordan Winter
Stephen W. Behrman
Nicholas J. Zyromski
Vic Velanovich
Kimberly Brown
Katherine A. Morgan
Charles Vollmer
Publikationsdatum: 01.01.2015
Verlag: Springer US
Erschienen in: Journal of Gastrointestinal Surgery / Ausgabe 1/2015
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI: https://doi.org/10.1007/s11605-014-2640-z

Neu im Fachgebiet Chirurgie

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Recycling im OP – möglich, aber teuer

05.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO₂-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Im OP der Zukunft läuft nichts mehr ohne Kollege Roboter

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Nur selten Nachblutungen nach Abszesstonsillektomie

03.05.2024 Tonsillektomie Nachrichten

In einer Metaanalyse von 18 Studien war die Rate von Nachblutungen nach einer Abszesstonsillektomie mit weniger als 7% recht niedrig. Nur rund 2% der Behandelten mussten nachoperiert werden. Die Therapie scheint damit recht sicher zu sein.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

The Value of Drains as a Fistula Mitigation Strategy for Pancreatoduodenectomy: Something for Everyone? Results of a Randomized Prospective Multi-institutional Study